Status:

COMPLETED

A Clinical Study to Evaluate Efficacy and Tolerability of a Cosmetic Product for Arm Firming

Lead Sponsor:

Revision Skincare

Collaborating Sponsors:

Stephens & Associates, Inc.

Conditions:

Photodamaged Skin

Skin Care

Eligibility:

FEMALE

40-60 years

Phase:

NA

Brief Summary

This single-center, split-body, double-blind, randomized, controlled clinical trial was conducted to assess the efficacy and tolerance of a topical firming body moisturizer when used over the course o...

Detailed Description

This single-center, split-body, double-blind, randomized, controlled clinical trial is being conducted to assess the efficacy and tolerance of the topical firming body moisturizer when used over the c...

Eligibility Criteria

Inclusion

  • Age range between 40 and 60 years
  • Mild to moderate skin crepiness upper arm region
  • Mild to moderate sagging skin upper arm region
  • Mild to moderate overall photodamage upper arm region
  • Willing to maintain their body weight within +/- 6.5 pounds

Exclusion

  • Diagnosed with known allergies to skin care products
  • Who have had massive weight loss
  • Who have undergone liposuction and/or weight loss surgery in the last 5 years.
  • Who are nursing
  • Who are pregnant
  • History of skin cancer within the past 5 years.
  • Having a health condition
  • Having a history of immunosuppression/immune deficiency disorders
  • Currently using oral or systemic immunosuppressive medications and biologics
  • Currently using or having regularly used corticosteroids
  • Having a disease such as asthma
  • Having started a long-term medication within the last 2 months.
  • Who started hormone replacement therapies (HRT)
  • Having had brachioplasty (upper arm lift);
  • Having liposuction
  • Having cryolipolysis
  • Having undergone a weight-loss diet or exercise habit change in the last 3 months or planning to start either during the study.
  • Having used any of the indicated products or had any of the listed procedures on the upper arms within the indicated time frame prior to the study start date.

Key Trial Info

Start Date :

December 13 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 17 2019

Estimated Enrollment :

46 Patients enrolled

Trial Details

Trial ID

NCT04065035

Start Date

December 13 2018

End Date

July 17 2019

Last Update

August 22 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Stephens and Associates

Richardson, Texas, United States, 75081